Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
about
Therapeutic modification of arterial stiffness: An update and comprehensive reviewImpact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort studyAssociation between renin and atherosclerotic burden in subjects with and without type 2 diabetes.Effects of inaccuracies in arterial path length measurement on differences in MRI and tonometry measured pulse wave velocity.The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes.T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control.Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes.Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study.Development and Validation of a Path Length Calculation for Carotid-Femoral Pulse Wave Velocity Measurement: A TASCFORCE, SUMMIT, and Caerphilly Collaborative Venture.Shared Genetic Contribution of Type 2 Diabetes and Cardiovascular Disease: Implications for Prognosis and Treatment.
P2860
Q26774555-92E99DE3-5084-4C1E-B756-61E022458CBEQ33771349-20D40B17-F1AC-436B-A2CE-25ECAD66201CQ36123417-952ADA62-A725-4ABE-AE6C-7E7AE0FBCCFDQ36367264-C4AE9CFF-A2FA-451E-A763-30D6AF23A5A9Q36654289-AFD23A72-171D-4638-8F8C-4CFDC7113F3DQ38430526-89DE8B88-C86F-45C8-A036-8EE8F2D2C2B8Q38524435-5999AC78-7E56-4689-AAD5-C9BFF21016DCQ41712441-67C78689-EA4F-424B-80B6-BB095C83F2E4Q49676867-134DBA44-7615-42B4-9D91-F668CC11AE24Q51286733-D9F15289-EE1D-46F0-9D6D-7B2F822D8F7BQ52648061-100E446C-D83F-4DC9-99B0-8B6130648553Q55468641-C8F25DD6-B3A3-4A43-AB48-2EF81CA3280E
P2860
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
description
article
@en
im April 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2015
@uk
name
Measures of atherosclerotic bu ...... European cross-sectional study
@en
Measures of atherosclerotic bu ...... European cross-sectional study
@nl
type
label
Measures of atherosclerotic bu ...... European cross-sectional study
@en
Measures of atherosclerotic bu ...... European cross-sectional study
@nl
prefLabel
Measures of atherosclerotic bu ...... European cross-sectional study
@en
Measures of atherosclerotic bu ...... European cross-sectional study
@nl
P2093
P2860
P50
P921
P356
P1476
Measures of atherosclerotic bu ...... European cross-sectional study
@en
P2093
C Kennbäck
C Ladenvall
H C Looker
P2860
P304
P356
10.1111/JOIM.12359
P407
P50
P577
2015-04-13T00:00:00Z